sor effect lasts about 5 hours (range = 2 to 24 hours). In animals,5 and in man6-8 diazoxide may cause salt and water retention that can be eliminated by the addition of a diuretic benzothiadiazine.
IN THE past 10 years many new drugs that lower blood pressure have been introduced for the treatment of hypertension. Several of them have not withstood the rigors of controlled clinical trials; others have faded away because side effects precluded their successful application. The useful hypotensive drugs developed have provided the physician one means to prolong the life of the individual with malignant hypertension, hypertensive heart failure, or encephalopathy and reverse many of the signs and symptoms of the disease. The purpose of this paper is to present our observations of the acute hemodynamic effects of a new hypotensive drug, diazoxide, in man.
Diazoxide is a nondiuretic benzothiadiazine synthesized by Dr. J. G. Topliss, M. H. Sherlock, and Dr. N. Sperber of the Chemical Research Division, Schering Corporation, and subsequently evaluated for hypotensive and diuretic activities.2 3 It lacks the free sulfamyl group that chlorothiazide possesses. It also has a methyl group in the 3 position and chloride in the 7 instead of the 6 position. When given intravenously to dogs, diazoxide decreases arterial pressure and total peripheral resistance, but increases heart rate, stroke volume, cardiac output, transmural right atrial pressure, and isometric myocardial contractile strength.4 In man arterial pressure is lowered within 30 seconds. Supine as well as standing pressures are reduced. The depres-sor effect lasts about 5 hours (range = 2 to 24 hours). In animals,5 and in man6-8 diazoxide may cause salt and water retention that can be eliminated by the addition of a diuretic benzothiadiazine.
Materials and Methods
All patients studied were from the Moore Clinic of the Johns Hopkins Hospital, Baltimore. Observations were made on 14 Negro subjects who were divided into three groups. The first group was composed of five hypertensive patients with an average age of 48 years, and an average mean arterial blood pressure of 132 mm. Hg. There were three women and two men. The second group was composed of five normotensive subjects with an average age of 46 years and an average mean arterial pressure of 110 mm. Hg. There were two women and three men. The third group contained four hypertensive patients whose average age was 41 years and average mean arterial pressure 131 mm. Hg. The groups did not differ in average body surface area or hypertensive classification (except the normotensive subjects).9 None of the 14 patients had received hypotensive drugs for the preceding 2 weeks.
On the day of the acute study, each patient was in a fasting state. No sedative was given. Measurements of right atrial pressure, systemic arterial pressure, cardiac output, and heart rate were made with the patient in the supine position. A small catheter was introduced through the basilic vein and advanced until its tip was lying free within the right atrium. A Cournand needle was placed in a brachial artery. Pressures were recorded from the right atrium and brachial artery with Statham strain gages. Mean pressures were obtained by electrical integration. Pressure recordings were made immediately before cardiac output determinations. The catheter in the right atrium was filled with indocyanine green dye connected through a three-way stopcock to a dye reservoir and injection system. The needle in the brachial artery was connected through a short, small-bore, polyethylene tubing to the euvette of a Gilford densitometer. Dye Systemic arterial pressure. At the 15-and 60-minute periods following diazoxide the hypertensive patients had a significant decrease in supine mean arterial pressure of greater than 20 mm. Hg. The normotensive patients had a similar reduction in arterial pressure at both periods. The control subjects given the NaOH buffer solution showed no significant changes in arterial pressure.
Pulse rate. The mean pulse rates of the three groups were approximately equal in the control periods. Fifteen minutes after diazoxide infusion, a significant increase in pulse rate occurred in both the hypertensive and normotensive subjects. The average increases were 28 beats per minute (p < 0.01), and 27 beats per minute (p < 0.01), respectively. One hour after diazoxide, the tachyeardia was still present in the hypertensive group, but had decreased toward control values in the normotensive subjects. Infusion of the NaOH buffer solution did not alter heart rate appreciably at either time interval.
Cardiac England, 14 and in this country. Future investigations in animals of the mechanism of the hyperglycemic effect of diazoxide singly, and combined with a thiazide diuretic, however, seem warranted. The completed studies of diazoxide in animals and in man have contributed additional support to the hypothesis that the depressor effect of the benzothiadiazines may be independent of their actions on the renal excretion of sodium.
Summary and Conclusions
The acute hemodynamic effects of the nondiuretic benzothiadiazine, diazoxide, were measured in five hypertensive patients and five normotensive subjects.
In both groups diazoxide produced a significant and prompt reduction in supine arterial blood pressure, an increase in heart rate and cardiac output, a marked decrease in peripheral resistance, but no change in right atrial mean pressure or stroke volume. The depressor effect of this drug in man is caused by a reduction in systemic arteriolar tone.
Chronic oral administration of diazoxide, when combined with a diuretic benzothiadiazine, is associated with a significant incidence of hyperglycemia especially, but not exclusively, in patients with diabetic glucose tolerance tests. Hirsutism is another untoward reaction. The mechanisms of these toxic effects are not known.
The rapid onset of its depressor action and the lack of reduction in cardiac output suggest that parenteral diazoxide may be a useful drug in selected patients with hypertensive emergencies. Additional cautious trial of intravenous diazoxide in patients with severe Circulation, Volume XXVIII, July 1968 hypertension seems indicated, although further evaluation may reveal other side effects that will preclude its usefulness even in such circumstances.
